Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epistaxis in Patients Receiving Oral Anticoagulants and Antiplatelet: Prevalence Risk Factors at a Tertiary Care Hospital in Nepal

NCT06906861 is registered in ClinicalTrials.gov with Institute of medicine, Maharagjung medical campus as lead sponsor.

NCT NCT06906861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06906861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epistaxis in Patients Receiving Oral Anticoagulants and Antiplatelet: Prevalence Risk Factors at a Tertiary Care Hospital in Nepal
Lead sponsor
Institute of medicine, Maharagjung medical campus
Phase
Observational
Overall status
Completed
Start date
November 1, 2023
Completion date
November 10, 2024
Enrollment
284 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epistaxis